Triamterene And Hydrochlorothiazide
Product Images NDC 51655-631

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Triamterene And Hydrochlorothiazide (NDC 51655-631). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 631 26 Master Bottle Label Approval Rev A 05 20)

Label (51655 631 26 Master Bottle Label Approval   Rev A 05 20)
This appears to be a label of a medication. The medication is identified as "Triamterene and Hydrochlorothiazide Tablets, USP" with a National Drug Code (NDC) of 51655-631:26 and comes in a bottle with 90 tablets. The dosage and storage information are mentioned on the label.*
FDA Label Image

Triamterene Chemical Structure (Image 1)

FDA Label Image

Hydrochlorothiazide Chemical Structure (Image 2)

Hydrochlorothiazide Chemical Structure (Image 2)
Hydrochlorothiazide is a medication that belongs to the class of thiazide diuretics. It is used to treat high blood pressure and edema (fluid retention) caused by various medical conditions including congestive heart failure, kidney disorders, and liver cirrhosis. Hydrochlorothiazide works by increasing the amount of urine produced by the kidneys, which helps to reduce the excess fluid in the body and control blood pressure. It is usually taken orally and is available in tablet form. However, it may cause some side effects like dizziness, headache, and increased sensitivity to the sun.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.